Free Trial

Zura Bio (ZURA) Stock Price, News & Analysis

Zura Bio logo
$1.14 +0.02 (+1.43%)
Closing price 07/3/2025 03:02 PM Eastern
Extended Trading
$1.13 0.00 (-0.44%)
As of 07/3/2025 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Zura Bio Stock (NASDAQ:ZURA)

Key Stats

Today's Range
$1.12
$1.16
50-Day Range
$1.00
$1.54
52-Week Range
$0.97
$5.07
Volume
129,512 shs
Average Volume
464,364 shs
Market Capitalization
$77.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.33
Consensus Rating
Buy

Company Overview

Zura Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

ZURA MarketRank™: 

Zura Bio scored higher than 66% of companies evaluated by MarketBeat, and ranked 331st out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zura Bio has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Zura Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Zura Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Zura Bio are expected to decrease in the coming year, from ($0.65) to ($0.78) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zura Bio is -1.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zura Bio is -1.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zura Bio has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Zura Bio's valuation and earnings.
  • Percentage of Shares Shorted

    6.91% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 13.31%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zura Bio does not currently pay a dividend.

  • Dividend Growth

    Zura Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.91% of the float of Zura Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Zura Bio has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Zura Bio has recently decreased by 13.31%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Zura Bio has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Zura Bio this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for ZURA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zura Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.23% of the stock of Zura Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    61.14% of the stock of Zura Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zura Bio's insider trading history.
Receive ZURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter.

ZURA Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Zura Bio price target lowered to $3 from $5 at H.C. Wainwright
Zura Bio (ZURA) Gets a Buy from Guggenheim
See More Headlines

ZURA Stock Analysis - Frequently Asked Questions

Zura Bio's stock was trading at $2.50 at the start of the year. Since then, ZURA stock has decreased by 54.6% and is now trading at $1.1360.

Zura Bio Limited (NASDAQ:ZURA) released its quarterly earnings results on Thursday, May, 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.02.

Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zura Bio investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Walt Disney (DIS).

Company Calendar

Last Earnings
5/08/2025
Today
7/05/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZURA
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.33
High Stock Price Target
$26.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+1,161.7%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.27 per share
Price / Book
0.50

Miscellaneous

Free Float
58,645,000
Market Cap
$77.68 million
Optionable
Optionable
Beta
-0.10
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ZURA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners